相似文献
1
The significance of monoclonal gammopathy of undetermined significance.
Haematologica. 2009 Dec;94(12):1641-4. doi: 10.3324/haematol.2009.013961.
2
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
Haematologica. 2009 Dec;94(12):1714-20. doi: 10.3324/haematol.2009.010066. Epub 2009 Jul 16.
3
Prognostic factors in monoclonal gammopathy of undetermined significance.
Haematologica. 2008 Jan;93(1):153-4. doi: 10.3324/haematol.11744.
4
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):187-90. doi: 10.1016/j.clml.2013.02.010. Epub 2013 Mar 13.
5
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.
Am J Hematol. 2019 May;94(5):E146-E149. doi: 10.1002/ajh.25441. Epub 2019 Mar 6.
6
Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):177-186.e4. doi: 10.1016/j.clml.2014.09.004. Epub 2014 Sep 28.
7
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Hematol Oncol Clin North Am. 2007 Dec;21(6):1093-113, ix. doi: 10.1016/j.hoc.2007.08.005.
8
Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol. 2017 Dec;179(5):849-851. doi: 10.1111/bjh.14266. Epub 2016 Sep 8.
9
Survival of cancer patients with prior monoclonal gammopathy of undetermined significance.
Eur J Intern Med. 2010 Dec;21(6):564-8. doi: 10.1016/j.ejim.2010.08.010. Epub 2010 Sep 19.
10
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
JAMA Oncol. 2015 May;1(2):168-74. doi: 10.1001/jamaoncol.2015.23.
引用本文的文献
1
Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo.
Am J Cancer Res. 2015 Feb 15;5(3):1000-16. eCollection 2015.
2
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Blood. 2014 Sep 25;124(13):2051-60. doi: 10.1182/blood-2014-02-555813. Epub 2014 Jul 24.
3
Association between the delta estimated glomerular filtration rate and the prevalence of monoclonal gammopathy of undetermined significance in Korean males.
Biomed Res Int. 2014;2014:356080. doi: 10.1155/2014/356080. Epub 2014 May 8.
4
Cellular mechanisms of multiple myeloma bone disease.
Clin Dev Immunol. 2013;2013:289458. doi: 10.1155/2013/289458. Epub 2013 May 29.
5
Can we change the disease biology of multiple myeloma?
Leuk Res. 2012 Nov;36 Suppl 1(0 1):S3-12. doi: 10.1016/S0145-2126(12)70003-6.
6
Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome.
Case Rep Genet. 2011;2011:143132. doi: 10.1155/2011/143132. Epub 2011 Dec 1.
7
Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.
Semin Hematol. 2011 Jan;48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003.
本文引用的文献
1
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
Haematologica. 2009 Dec;94(12):1714-20. doi: 10.3324/haematol.2009.010066. Epub 2009 Jul 16.
2
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
Blood. 2009 Jun 18;113(25):6386-91. doi: 10.1182/blood-2009-02-203471. Epub 2009 Apr 22.
3
A monoclonal gammopathy precedes multiple myeloma in most patients.
Blood. 2009 May 28;113(22):5418-22. doi: 10.1182/blood-2008-12-195008. Epub 2009 Feb 20.
4
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Blood. 2009 Jul 23;114(4):785-90. doi: 10.1182/blood-2008-12-192575. Epub 2009 Jan 29.
5
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
Blood. 2009 May 28;113(22):5412-7. doi: 10.1182/blood-2008-12-194241. Epub 2009 Jan 29.
6
Long-term follow-up of a population based cohort with monoclonal proteinaemia.
Br J Haematol. 2009 Jan;144(2):176-84. doi: 10.1111/j.1365-2141.2008.07423.x. Epub 2008 Nov 19.
7
Epidemiology of the plasma-cell disorders.
Best Pract Res Clin Haematol. 2007 Dec;20(4):637-64. doi: 10.1016/j.beha.2007.08.001.
8
Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
Mayo Clin Proc. 2007 Dec;82(12):1474-9. doi: 10.1016/S0025-6196(11)61090-2.
9
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
Mayo Clin Proc. 2007 Dec;82(12):1468-73. doi: 10.1016/S0025-6196(11)61089-6.
10
Clinically relevant end points and new drug approvals for myeloma.
Leukemia. 2008 Feb;22(2):231-9. doi: 10.1038/sj.leu.2405016. Epub 2007 Nov 1.
Zotero 插件